Jaehne Emily Joy, Salem Abdallah, Irvine Rodney James
Discipline of Pharmacology, School of Medical Sciences, Level 5 Medical School North, University of Adelaide, Adelaide, SA, 5005, Australia.
Psychopharmacology (Berl). 2008 Dec;201(2):161-70. doi: 10.1007/s00213-008-1258-9. Epub 2008 Aug 6.
3,4-Methylenedioxymethamphetamine (MDMA, "ecstasy") disrupts thermoregulation in rats and can lead to life-threatening hyperthermia in humans. MDMA administration can also lead to long-term neurotoxicity in animals and possibly humans.
The purpose of the current study was to extend previous results on the acute effects of MDMA on behavioral thermoregulation to a repeated dosing regime, simulating regular weekend use of ecstasy, on measures of thermoregulation and heart rate (HR).
Sprague-Dawley rats with telemetry implants were administered 40 micromol/kg MDMA on three consecutive days each week for 1 or 6 weeks before being confined to an elevated ambient temperature (TA) (HOT; 30+/-1 degrees C) or an area at room temperature (ROOM; 21.5+/-1.5 degrees C) for 30 min. After the final drug administration, rats were placed in a thermal gradient for 4 h to allow behavioral thermoregulation.
HOT rats showed higher core temperature (TC), HR, and locomotor activity than ROOM rats during confinement to a set TA (P<0.001). HR responses to MDMA over 6 weeks at both TAs progressively decreased with repeated dosing (P<0.05). TC was significantly higher in both 6-week groups compared to the 1-week groups (P<0.05) at the end of time in the gradient. Cortical concentrations of dihydroxyphenylacetic acid (DOPAC; P<0.05) and 5-hydroxyindole acetic acid (5-HIAA; P<0.001) decreased significantly irrespective of TA, while concentrations of dopamine and 5-HT did not change.
Long-term treatment with MDMA resulted in apparent tolerance to the effects of the drug on HR, dysregulation of TC in thermal gradient, and depletion of cortical DOPAC and 5-HIAA.
3,4-亚甲基二氧甲基苯丙胺(摇头丸,MDMA)会扰乱大鼠的体温调节,可导致人类出现危及生命的高热。服用摇头丸还会导致动物以及可能在人类中产生长期神经毒性。
本研究的目的是将先前关于摇头丸对行为体温调节急性影响的结果扩展到重复给药方案,模拟周末定期使用摇头丸,以研究体温调节和心率(HR)指标。
将植入遥测装置的Sprague-Dawley大鼠,每周连续三天给予40微摩尔/千克摇头丸,持续1周或6周,然后置于高温环境(热环境;30±1℃)或室温区域(室温环境;21.5±1.5℃)30分钟。在最后一次给药后,将大鼠置于热梯度环境中4小时,以进行行为体温调节。
在固定环境温度下,热环境大鼠的核心体温(TC)、心率和运动活动高于室温环境大鼠(P<0.001)。在两个环境温度下,摇头丸在6周内对心率的反应随着重复给药逐渐降低(P<0.05)。在热梯度环境中,6周组的核心体温在时间结束时均显著高于1周组(P<0.05)。无论环境温度如何,二羟基苯乙酸(DOPAC;P<0.05)和5-羟吲哚乙酸(5-HIAA;P<0.001)的皮质浓度均显著降低,而多巴胺和5-羟色胺浓度未发生变化。
长期服用摇头丸导致对药物对心率的影响产生明显耐受性,热梯度环境中核心体温调节失调,以及皮质DOPAC和5-HIAA耗竭。